Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 283, Issue 5 27-5, 2002, Pages

  Schmidt, R ^a   Meier, U ^a   Markart, P ^a   Grimminger, F ^a   Velcovsky, H G ^a   Morr, H ^a   Seeger, W ^a   Gunther A ^a,b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Klinik für Lungen und Bronchialerkrankungen Waldhof Elgershausen   (Germany)

Author keywords

Hypersensitivity pneumonitis; Idiopathic pulmonary fibrosis; Pulmonary surfactant; Sarcoidosis; Surface activity

Indexed keywords

CHOLINE; ETHANOLAMINE; GLYCEROL; INOSITOL; LUNG SURFACTANT; PALMITIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPID; SERINE;

ADULT; ALLERGIC PNEUMONITIS; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID COMPOSITION; LUNG ALVEOLUS SURFACE TENSION; LUNG FIBROSIS; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; SARCOIDOSIS;

EID: 0036838925     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00484.2001     Document Type: Article

References (36)

1. American Thoracic Society and European Respiratory Society. Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161: 646-664, 1985.
2. Baughman RP, Strohofer S, and Dohn M. Decreased phosphatidylcholine in the lung fluid of patients with sarcoidosis. Lipids 20: 496-499, 1985.
3. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
4. Burdge GC, Kelly FJ, and Postle AD. Synthesis of phosphatidylcholine in guinea-pig fetal lung involves acyl remodelling and differential turnover of individual molecular species. Biochim Biophys Acta 161: 251-257, 1993.
5. Christie WW. High Performance Liquid Chromatography And Lipids - A Practical Guide. Oxford, UK: Pergamon, 1987, p. 55-63.
6. Egberts J, Sloot H, and Mazure A. Minimal surface tension, squeeze-out and transition temperatures of binary mixtures of dipalmitoylphosphatidylcholine and unsaturated phospholipids. Biochim Biophys Acta 1002: 109-113, 1989.
7. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 43: 198-203, 1977.
8. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA III, Hudson LD, Maunder RJ, Crim C, and Hyers TM. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88: 1976-1981, 1991.
9. Günther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, and Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153: 176-184, 1996.
10. Gustavsson L. Densitometric quantification of individual phospholipids. Improvement and evaluation of a method using molybdenum blue reagent for detection. J Chromatogr 375: 255-266, 1986.
11. Hallman M, Spragg R, Harrell JH, Moser KM, and Gluck L. Evidence of lung surfactant abnormality in respiratory failure. J Clin Invest 70: 673-683, 1982.
12. Hawco MW, Coolbear KP, Davis PJ, and Keough KM. Exclusion of fluid lipid during compression of monolayers of mixtures of dipalmitoylphosphatidylcholine with some other phosphatidylcholines. Biochim Biophys Acta 646: 185-187, 1981.
13. Hawco MW, Davis PJ, and Keough KM. Lipid fluidity in lung surfactant: Monolayers of saturated and unsaturated lecithins. J Appl Physiol 51: 509-515, 1981.
14. Heeley E, Wright S, Wilton D, and Postle A. Molecular species of acidic phospholipids in human lung surfactant. Biochem Soc Trans 26: S227, 1998.
15. Honda Y, Tsunematsu K, Suzuki A, and Akino T. Changes in phospholipids in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Lung 166: 293-301, 1988.
16. Hughes DA and Haslam. PL. Changes in phosphatidylglycerol in bronchoalveolar lavage fluids from patients with cryptogenic fibrosing alveolitis. Chest 95: 82-89, 1989.
17. Johansson J and Curstedt T. Molecular structures and interactions of pulmonary surfactant components. Eur J Biochem 244: 675-693, 1997.
18. Kronenberger H, Meier-Sydow J, Bauer E, Muller R, Fleischer W, Nerger K, and Thiel C. A new questionnaire for the detection of causes of lung and respiratory tract diseases. Prax Klin Pneumol 39: 233-251, 1985.
19. Kunitake R, Kuwano K, Yoshida K, Maeyama T, Kawasaki M, Hagimoto N, and Hara N. KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Respiration 68: 488-495, 2001.
20. Low RB, Davis GS, Bell DY, Giancola MS, and Vacek PM. Lipids in bronchoalveolar lavage fluid from patients with sarcoidosis. Thorax 42: 926-932, 1987.
21. McCormack FX, King TE, Voelker DR, Robinson PC, and Mason RJ. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis 144: 160-166, 1991.
22. Myher JJ, Kuksis A, and Pind S. Molecular species of glycerophospholipids and sphingomyelins of human erythrocytes: Improved method of analysis. Lipids 24: 396-407, 1989.
23. Myher JJ, Kuksis A, and Pind S. Molecular species of glycerophospholipids and sphingomyelins of human plasma: Comparison to red blood cells. Lipids 24: 408-418, 1989.
24. Notter RH, Holcomb S, and Mavis RD. Dynamic surface properties of phosphatidylglycerol-dipalmitoylphosphatidylcholine mixed films. Chem Phys Lipids 27: 305-319, 1980.
25. Notter RH, Tabak SA, and Mavis RD. Surface properties of binary mixtures of some pulmonary surfactant components. J Lipid Res 21: 10-22, 1980.
26. Pastrana-Rios B, Flach CR, Brauner JW, Mautone AJ, and Mendelsohn R. A direct test of the "squeeze-out" hypothesis of lung surfactant function. External reflection FT-IR at the air/water interface. Biochemistry 33: 5121-5127, 1994.
27. Post M, Schuurmans EA, Batenburg JJ, and Van Golde LM. Mechanisms involved in the synthesis of disaturated phosphatidylcholine by alveolar type II cells isolated from adult rat lung. Biochim Biophys Acta 750: 68-77, 1983.
28. Postle AD, Heeley EL, and Wilton DC. A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Compar Biochem Physiol A Mol Integr Physiol 129: 65-73, 2001.
29. Robinson PC, Watters LC, King TE, and Mason RJ. Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids. Am Rev Respir Dis 137: 585-591, 1988.
30. Rouser G, Fleischer S, and Yamamoto A. Two-dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5: 494-496, 1970.
31. Schmidt R, Meier U, Yabut-Perez M, Walmrath D, Grimminger F, Seeger W, and Günther A. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome (ARDS) and severe pneumonia. Am J Respir Crit Care Med 163: 95-100, 2001.
32. Seeger W, Guenther A, and Thede C. Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants. Am J Physiol Lung Cell Mol Physiol 262: L286-L291, 1992.
33. Tanaka Y, Takei T, and Masuda K. Lung surfactants. III. Correlations among activities in vitro, in situ and in vivo, and chemical composition. Chem Pharm Bull (Tokyo) 31: 4110-4115, 1983.
34. Veldhuizen R, Inchley K, Hearn SA, Lewis JF, and Possmayer F. Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates. Biochem J 295: 141-147, 1993.
35. Veldhuizen R, Nag K, Orgeig S, and Possmayer F. The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1408: 90-108, 1998.
36. Wright RS. A reagent for the nondestructive location of steroids and some other lipophilic materials on silica gel thin-layer chromatograms. J Chromatogr 59: 220-221, 1971.